Published in Medicine and Law Weekly, January 19th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Stem Cell Therapeutics.
Report 1: Stem Cell Therapeutics Corp. (SCT) announced the formation of its clinical advisory board (CAB) with three well-known clinicians, Steven Cramer, MD, Hannelore Ehrenreich, MD, and Michael Hill, MD, who have agreed to provide input and guidance on SCT's current stroke program with NTx-265.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly